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Abstract
The purpose and objectives of this work were to study the nature of the heart, lungs and kidneys angiopathy in rats 
with a model of systemic autoimmune disease, carrying out comparisons of the results with extravasal morphological man-
ifestations of the pathological process, the state of vascular endothelial function and activity of pro-inflammatory cytokines 
in the blood. The experiment was conducted on 40 non-linear rats. To simulate the disease animals were injected by complete 
Freund’s adjuvant, a solution of splenic deoxyribonucleic acid cattle, mercaptopurine, methyluracilum and with food rats 
constantly received sulfate cadmium, lithium hydroxybutyrate and ammonium molybdate. Within two months from the start 
of the study animals were taken out of the experiment on the background of intraperitoneal nembutal anesthesia. Histological 
sections of the heart, lung and kidney tissue were stained with hematoxylin-eosin, alcian blue and by van-Gieson, becoming 
the PAS-reaction. In the animals with the proposed experimental model of systemic autoimmune disease observed morpho-
logical characteristics of lesions of the heart blood vessels, lungs and kidneys, the nature of the manifestations of which were 
interconnected with each other, which confirms the common pathogenetic angiopathy constructions at various diseases in clin-
ical practice. In the genesis of cardiac, pulmonary and renal vessels lesions act the activation of pro-inflammatory cytokines 
and violation of vascular endothelial function, which has a certain practical significance. In clinical practice, not only purely 
systemic vasculitis, and other autoimmune diseases should be treated as angiopathy.
Keywords: autoimmune disease, experiment, rats, vessels.
DOI: 10.21303/2504-5679.2017.00262 © Yelizaveta Iegudina, Pavel Yakovlenko, Oleg Syniachenko, Viktoriya Mikuksts 
1. Introduction
The prevalence of systemic autoimmune diseases is increasing everywhere [1–3], and the 
changes in heart, lungs and kidneys vessels are considered as common for them, besides the pres-
ence of various autoantibodies in serum [4–8]. The pathogenesis of such angiopathy (vasculopa-
thy) remains studied not enough [9, 10], although the severity of vascular damage determines the 
prognosis of these diseases [11, 12]. Animal experiments can improve the information about the 
role of vascular pathology in the pathogenic constructions of heart, lungs and kidneys lesions in the 
autoimmune systemic diseases, but the results of the following studies are still very controversial 
and require to be further solved [13–15].
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2. The purpose and objectives of the study
To explore the nature of heart, lungs and kidneys vascular lesions in rats with autoimmune 
systemic disease model, to make a comparison between the results of extravascular morphological 
manifestations of the pathological process, vascular endothelial function and proinflammatory cy-
tokines activity in the serum.
3. Material and methods
The experiment was conducted in 40 non-linear rats (10 females and 30 males) with 
average weight about 250 grams, according to the modified methodology which we have been 
proposed before [16]. To simulate the disease we used the complete Freund’s adjuvant (CFA) 
and the solution of cattle’s splenic deoxyribonucleic acid (DNA) (5 mg/kg of animal’s mass) 
which were inserted at the root of the tail under the ether inhalation anesthesia. In two weeks 
mercaptopurine was administered (50 mg/kg) through a special tube into the stomach, and 
CFA and DNA (2.5 mg/kg) – in the root of the tail. On the next day during one week animals 
were administered methyluracilum into the stomach daily (200 mg/kg) and then repeated ad-
ministration of mercaptopurine (50 mg/kg), CFA (1.5 mg/kg) and DNA (1.5 mg/kg). Then 
during the week animals were given methyluracilum (100 mg/kg). The rats received about 0.1 
mg of cadmium sulfate, 500 mg of lithium hydroxybutyrate and 0.3 mg of ammonium molyb-
date with food regularly (at the rate per animal). In two months after the beginning of the study 
against the background of intraperitoneal nembutal anesthesia (50 mg/kg) animals were taken 
out of the experiment. The control group consisted of 20 intact rats.
Histological sections of heart, lungs and kidneys tissue were stained with hematoxy-
lin-eosin, alcian blue (on glycoproteins) and with the method of van-Gieson (collagen and elastic 
fibers), PAS-reaction was conducted. Vascular and extravascular heart, lungs and kidneys lesions 
were evaluated in scores (0 to 3). There was calculated the average damage index (ADI) using 
a formula: ADI=(a+2b+3c):(a+b+c+d), where “a, b, c” – the number of animals in accordance 
with 1, 2 and 3 points and “d” – the number of animals with the absence of this feature. The 
levels of proinflammatory cytokines – tumor necrosis factor α (TNFα) and interleukin 1β (IL1β) 
were studied in serum by immune-enzyme analysis (reader “PR2100 Sanofi diagnostic pasteur”, 
France), and the concentrations of endothelial vascular function – endothelin-1 (ET1) and cyclic 
guanosine monophosphate (cGMP) (immune-enzyme analysis (reader “PR2100 Sanofi diagnos-
tic pasteur”, France)) were associated with them.
Statistical analysis of the results of research was conducted by computer variation, 
correlation, regression, one-factor (ANOVA) and multiple (ANOVA/ MANOVA) analysis of 
variance (program “Microsoft Excel” and “Statistica-Stat-Soft”, USA). The mean values, 
their standard deviations and error rates, coefficient of parametric Pearson correlation (r) 
and nonparametric Kendall (τ), regression criteria (R), dispersion Brown-Forsythe (BF) and 
Wilcoxon-Rao (WR), Student’s test (t) and the probability of statistical indicators (p) were 
assessed. The critical level of significance in testing statistical hypotheses was considered as 
being equal to 0.05.
4. Results
In rats with the model of experimental autoimmune disease changes in the heart vessels 
were found in 82.5 % of cases, lungs – in 32.5 %, kidneys – in 72.5 %. ADI of vascular injuries 
was 1,07±0,332 points.
Morphological signs of vascular pathology of heart tissue are shown in the Fig. 1, 2. 
Changes in the lungs vessels of the animals with autoimmune disease model are shown in 
the Fig. 3, 4.
The proliferation of glomerular capillaries endothelium was revealed in the kidneys of 
82.5 % of the studied rats, proliferation of arterioles endothelium – in 65.0 %, cellular perivascular 
(mainly lymphohistiocytic) infiltration of stroma – in 40.0 % synechia of glomerular capsule with 
capillaries – in 27.5 %. These data are reflected in the Fig. 5, 6.
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Fig. 1. Heart preparation of a rat with autoimmune systemic disease.  
Perivascular sclerosis (van-Gieson staining, ×400)
Fig. 2. Heart preparation of a rat with autoimmune systemic disease.  
Proliferation of arteries endothelium, perivascular sclerosis  
(hematoxylin and eosin staining, ×400)
Fig. 3. Lung preparation of a rat with systemic autoimmune disease.  
Arterioles hyalinosis, perivascular lymphohistiocytic infiltration  
(hematoxylin and eosin staining, ×400)
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Fig. 4. Lung preparation of a rat with systemic autoimmune disease.  
Arterioles hyalinosis, perivascular lymphoplasmocytic infiltration  
(van-Gieson staining, ×400)
Fig. 5. Kidney preparation of a rat with autoimmune systemic disease.  
Adhesion of Bowman’s capsule with capillaries, perivascular histiocytic infiltration  
(hematoxylin and eosin staining, ×400)
Fig. 6. Kidney preparation of a rat with autoimmune systemic disease. Perivascular 
lymphohistiocytic infiltration in the stroma (hematoxylin and eosin staining, ×200)
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In intact animals ET1 levels in serum was 1,8±0,21 pg/ml, cGMP – 7,3±0,52 pmol/ml, TNFα – 
21,0±0,62 pg/ml, IL1β – 14,1±0,52 pg/ml. In the experimental autoimmune systemic disease the 
concentration of ET1 (t=9,02, p<0,001) increased in 3.4 times, TNFα (t=5,79, p<0,001) – in 69,6 %, 
IL1β (t=7,88, p<0,001) – in 78.8 %, but content of cGMP (t=3,16, p=0,010) decreased in 32.2 %. In 
the experimental group of rats there are direct links between ET1 and IL1β (r=+0,597, p=0,014).
5. Discussion 
In the animals with experimental model of autoimmune systemic disease are observed 
morphological characteristics of heart vessels lesions. Perivascular sclerosis of miocardium was 
detected in ¾ of the animals, venous plethora – in 52.5 %, vascular endothelial proliferation – in 
62.5 %, perivascular infiltration – in 42.5 %, vascular sclerosis/hyalinosis – in 35.5 %. ADI vessels 
directly correlated with ADI of endocardium and valves (r=+0,439, p=0,016). It is suggested the 
involvement of myocardial vessels in most animal models and interconnection between lesion of 
vessels and endocardium.
Morphological signs of vascular pathology of heart tissue are (in the decrescent order by fre-
quency): mucoid swelling of vessels, thickening of the vascular wall, proliferation of endothelium, 
fibrinoid swelling, intravascular aggregation of red blood cells, intravascular lymphohistiocytic 
infiltration, perivascular lymphohistiocytic infiltration, lymphohistiocytic infiltration of the vascu-
lar wall, fibrinoid necrosis, neutrophil infiltration of the vascular wall, proliferation of the intima, 
perivascular neutrophilic infiltration, giant cell infiltration, extravasation of erythrocytes.
Changes in the lungs vessels of the animals with autoimmune disease model are character-
ized by the thickening of the walls, mucoid swelling, angiospasm, endothelial proliferation, peri-
vascular lymphohistiocytic infiltration and mast cells infiltration, sclerosis/hyalinosis of vascular 
walls. There is abundant evidence that mast cells are active participants in events that mediate 
tissue damage in autoimmune disease.
According to multivariate analysis of variance Wilcoxon-Rao, integral degree changes 
of heart vessels significantly (p=0,009–p<0,001) depends on the severity of cardiomyocytes hy-
pertrophy (WR=10,07), its necrosis (WR=5,93), stromal edema (WR=8,28), lymphomacrophage 
its infiltration (WR=12,25), and perivascular cell infiltration (WR=5,71). In turn, miocardium 
angiopathy ADI influences on the severity of necrotic and sclerotic changes of endocardium, as 
Brown-Forsythe analysis indicated (correspondingly BF=8,23, p=0,004 and BF=9,77, p<0,001). 
These interconnections confirm the common pathogenetic factors for angiopathy constructions 
and organ’s damage.
According to the single-factor analysis of variance, the ADI of endocardium and valvular 
lesions influence the degree of vascular endothelium proliferation (BF=4,79, p=0,010). The sever-
ity of perivascular sclerosis affects the intensity of endocardium cellular infiltration (BF=3,88, 
p=0,023), the perivascular infiltration – endocardial necrotization (BF=4,25, p=0,025), and the peri-
vascular sclerosis – endocardial sclerosis (BF=5,33, p=0,009), the cardiomyocyte necrosis – prolifera-
tion of vascular endothelium (BF=3,34, p=0,035). The morphological characteristics of heart vascular 
lesions are connected to each other.
ADI of the kidneys and lungs vessels was about the same, accounting respectively 1,52±0,118 
and 1,50±0,174 points. The degree of proliferation of heart and lungs vascular endothelium directly 
correlated with the kidney ADI (respectively r=+0,521, p=0,018 and r=+0,538, p=0,008), and the 
severity of the kidney vascular endothelium lesion statistically significant (p<0,001) influence on 
the change of hearts and lungs endothelium (correspondingly BF=10,06 and BF=8,93).
According to the analysis of variance, sclerotic damage of kidneys’ capillaries and arte-
rioles depend on the degree of proliferation of heart vascular endothelium (BF=7,47, p=0,008), 
and ADI of lungs vessels – on the endothelial proliferative changes of renal vessels (BF=4,58, 
p=0.017). Regression analysis shows the direct influence of vascular heart endothelium de-
gree proliferation on venous plethora (R=+4,20, p=0,026), perivascular infiltration (R=+8,11, 
p<0,001) and sclerosis of the heart vessels (R=+2,56, p=0,040) are up to the condition of the 
pulmonary vessels, sclerosis/hyalinosis of renal arterioles (R=+3,08, p=0,019) – pulmonary 
vascular endothelium. Kendall nonparametric analysis found direct correlation between scle-
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rotic symptoms of heart and lungs vessels (τ=+0,247, p=0,012), heart and kidney (τ=+0,183, 
p=0,038), lungs and kidney (τ=+0,204, p=0.025). It shows the similarity of pathogenetic theo-
ries of angiopathy in autoimmune diseases.
The degree of proliferation of endothelium and vascular sclerosis influence the integrated 
state of vascular endothelial function in animal with model of autoimmune systemic disease as in-
dicated the multivariate analysis of variance ANOVA/MANOVA (accordingly WR=2,36, p=0,035 
and WR=2,72, p=0,013). Univariate Brown-Forsythe analysis shows the effect of ET1 parameters 
on the severity of kidney vessels endothelium proliferation (BF=4,16, p=0,029), and the concentra-
tion of IL1β – on the heart vessels endothelium proliferation (BF=12,05, p<0,001). In the genesis of 
cardiac, pulmonary and renal vessels lesions act the activation of pro-inflammatory cytokines and 
violation of vascular endothelial function
It should be noted that in the experimental autoimmune vascular pathology there is a com-
plex system of protection of endothelial cells, which is directed to inhibition of pro-inflammatory 
cytokines, matrix metalloproteinases and C-dependent protein kinase [17]. Protection of nitrogen 
oxide relatively to endothelial dysfunction is negligible, and in the linear mice C57Bl/B6j, NZB/W 
and MRL/1 with immune disorders the additional input of autoantibodies to the basement membrane 
of vessels is accompanied by the generation of molecules of nitric oxide, but it does not prevent the 
adhesion of neutrophils to the endothelium of the capillaries and progression of the pathological pro-
cess [18–20]. Bradykinin can suppress the signs of endothelial dysfunction in model of autoimmune 
systemic disease that enhances vasodilation [21, 22].
Our review also revealed that most animal models only recapitulate some features of human 
disease but the genetic heterogeneity of individual human autoimmune diseases should be consid-
ered. A single rat strain is clearly unable to encompass the heterogeneity of the human population. 
Thus studies should not be restricted to the identification and/or use of a “gold standard” animal 
model. Rather models should be investigated that best reflect human genetic heterogeneity, and/or 
ask specific mechanistic questions that a particular model is able to address.
Information that presented in the study required for testing of vessels (carrying sonography, 
capillarography, conjunctival biomicroscopy etc.) in the early stages of observation of patients with 
systemic autoimmune diseases for timely accomplishment of appropriate preventive measures in 
the context of the identified angiopathy. There is still much to be learned about how angiopathy 
impact autoimmunity.
6. Conclusions
1. In the animals with experimental model of autoimmune systemic disease are observed 
morphological characteristics of heart, lungs and kidneys vascular lesions, the character of which 
manifestations are connected to each other, as evidence by similarity of pathogenetic theories of 
angiopathy in autoimmune diseases in clinical practice.
2. The activation of proinflammatory cytokines and vascular endothelial function abnor-
mality play a vital part in the genesis of cardiac, pulmonary and renal vessels lesions, which has a 
practical significance.
3. In clinical practice, not only systemic vasculitis (Henoch-Schonlein purpura, micro-
scopic polyangiitis, Granulomatosis with polyangiitis (Wegener), eosinophilic granulomatosis 
with polyangiitis (Churg-Strauss), polyarteritis nodosa, vasculitis Behcet and Kawasaki etc.) and 
other autoimmune systemic rheumatic diseases (systemic lupus erythematosus, systemic sclero-
derma, Sjogren’s disease, rheumatoid arthritis, ankylosing spondylitis etc.) should be considered 
as angiopathy.
4. The study of the heart, lungs and kidneys angiopathy nature in rats with a model of sys-
temic autoimmune disease can be used for a wider investigation of pathogenesis of autoimmune 
diseases and for searching new approaches to the treatment of these diseases.
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